Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
BioConferenceLive
JIB

New Line of Small Benchtop Centrifuges Minimizes Space Requirement While Maximizing Flexibility

By BiotechDaily International staff writers
Posted on 06 Jun 2013
 Image: The new Thermo Scientific SL 8 small benchtop centrifuge (Photo courtesy of Thermo Fisher Scientific).
Image: The new Thermo Scientific SL 8 small benchtop centrifuge (Photo courtesy of Thermo Fisher Scientific).
A new line of benchtop centrifuges was designed to provide exceptional capacity in a compact design with a smart, simple interface and the flexibility to support both clinical and research applications.

Sale of the new instrument was recently launched by Thermo Fisher Scientific Inc. (Milford, MA, USA). The new line of centrifuges is highlighted by a particularly compact footprint, which conserves valuable laboratory bench space. Nonetheless, the instrument can accommodate eight 50 mL tubes, four microplates, or 30 filtration columns in a swinging bucket rotor. The "Auto-Lock" rotor exchange enables rotor replacement in less than three seconds while delivering trouble-free rotor installation and removal and clear chamber access for cleaning convenience.

The centrifuges are manufactured with quality materials providing broad chemical resistance with exceptional strength for durability and reliability. The instrument is controlled via an intuitive glove and detergent friendly interface with a bright backlit display, featuring one-touch operation with preset protocol options and optional password protection.

“Centrifuges are critical laboratory resources that are in constant use and demand. It is crucial to avoid bottlenecks in these lab workflows that could create unwanted downtime and negatively impact users’ work,” said Maurizio Merli, product director at Thermo Fisher Scientific. “With features designed to optimize simplicity, safety, and flexibility, the new Thermo Scientific small benchtop centrifuges can help scientists save time and maximize resources in busy labs and clinics.”

Related Links:
Thermo Fisher Scientific Inc.




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.